AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Summary

AtriCure, a leader in surgical treatments for atrial fibrillation (Afib), has announced its participation in the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021, at 8:00 a.m. ET. The event will feature a live and archived audio webcast available on the company's website. AtriCure’s innovative technologies, including the Isolator® Synergy™ Ablation System and AtriClip® Left Atrial Appendage Exclusion System, are widely utilized for Afib treatment, impacting over 33 million individuals globally. For further details, visit AtriCure.com.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming SVB Leerink 10^th Annual Global Healthcare Conference.

AtriCure’s management is scheduled to present on Wednesday, February 24, 2021, at 8:00 a.m. Eastern Time. Interested parties may access a live and archived audio webcast of the presentation by visiting the “Investors” section of the company’s website at https://ir.atricure.com.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator^® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip^® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210210005183/en/

FAQ

What is the date of AtriCure's presentation at the SVB Leerink conference?

AtriCure's presentation is scheduled for February 24, 2021.

What time will AtriCure present at the conference?

AtriCure will present at 8:00 a.m. Eastern Time.

How can I access AtriCure's presentation?

You can access the live and archived audio webcast on AtriCure's Investors section at AtriCure.com.

What technologies does AtriCure provide for Afib treatment?

AtriCure offers the Isolator® Synergy™ Ablation System and AtriClip® Left Atrial Appendage Exclusion System for Afib management.

How many people are affected by Afib worldwide?

Afib affects more than 33 million people globally.